Evidence map›Paper›PMID 37366540›Full record

ArticleHistology and histopathology2024

Nomogram based on CMTM6 expression and clinical characteristics to predict postoperative overall survival in patients with hepatocellular carcinoma.

Mengjie Dai, Tao Lan, Hui Chen, Xin Li, Zilong Zhao, Yingxue Jiang, Long Yang, Songxiang Wang

Abstract read
PubMed Publisher
In one paragraph

Article in Histology and histopathology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 100% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Mengjie DaiCangzhou People's Hospital, Cangzhou, China.
Tao LanCangzhou People's Hospital, Cangzhou, China. sco13403249454@163.com.
Hui ChenCangzhou People's Hospital, Cangzhou, China.
Xin LiCangzhou People's Hospital, Cangzhou, China.
Zilong ZhaoCollege of Chemical Engineering, Northwest University, Xian, China.
Yingxue JiangCollege of Chemical Engineering, Northwest University, Xian, China.
Long YangCangzhou People's Hospital, Cangzhou, China.
Songxiang WangCangzhou People's Hospital, Cangzhou, China.
People's Hospital of Cangzhou · CNNorthwest University · CN

Funding

Hebei Province innovation ability promotion plan subsidy project 205A7701H
6 · The paper itself

Abstract

backgroundThe purpose of this study was to investigate the expression of CMTM6 in HCC tissues and its prognostic value, and to try to develop a nomogram prognostic model based on CMTM6.

methodsIn this retrospective study, immunohistochemical (IHC) staining was performed in 178 patients who underwent radical hepatectomy in the same surgical team. R software was used to construct the nomogram model. The Bootstrap sampling method was used for internal validation.

resultsCMTM6 is significantly expressed in HCC tissues and is closely associated with decreased overall survival (OS). PVTT (HR = 6.2, 95% CI: 3.06 12.6, P<0.001), CMTM6 (HR=2.30, 95% CI: 1.27 4.0, P=0.006) and MVI (HR=10.8, 95% CI: 4.19-27.6, P<0.001) were independent predictors of OS. The nomogram combined with CMTM6, PVTT and MVI was more predictive than the traditional TNM scoring system, and the prediction effects of 1-year and 3-year OS were accurate.

conclusionsThe prognosis of a patient may be predicted using high levels of CMTM6 expression in HCC tissues, and the nomogram model including CMTM6 expression has the best predictive ability.

Indexed as

Carcinoma, HepatocellularLiver NeoplasmsHumansNomogramsPrognosisRetrospective Studies

Identifiers

PMID37366540
OpenAlexW4382182798

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.